Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations - Concepedia

Concepedia

Publication | Open Access

Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations

DOI Full Paper Access

19

Citations

19

References

2024

Year

Maddalena Ardissino, Eric A. W. Slob, Rohin K. Reddy, Alec Morley, Art Schuermans, Phoebe Hill, Catherine Williamson, Michael C. Honigberg, Antonio de Marvao, Fu Siong Ng

European Journal of Preventive Cardiology

Abstract

These data provide genetic evidence supporting current manufacturer advice to avoid the use of PCSK9 inhibitors during pregnancy.

References

	Year	Citations

Page 1